INCR InterCure Ltd.
Healthcare$0.91+3.16%ClosedMarket Cap: $49.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.39
P/S
0.79
EV/EBITDA
-8.77
DCF Value
$-2.99
FCF Yield
6.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
21.7%
Operating Margin
-17.8%
Net Margin
-19.5%
ROE
-8.8%
ROA
-5.3%
ROIC
-4.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $270.2M | 12.3% | $6.7M | $-35.7M | $— | — |
| Q2 null | $65.0M | 30.9% | $2.9M | $-852.0K | $— | — |
| Q1 null | $65.0M | 30.9% | $2.9M | $-852.0K | $— | — |
| Q4 null | $56.6M | 0.3% | $-38.9M | $-34.6M | $— | — |
| FY null | $238.8M | 12.7% | $-67.2M | $-67.8M | $— | — |
| Q3 null | $56.6M | 0.3% | $-38.9M | $-34.6M | $— | — |
| Q2 null | $62.9M | 33.1% | $5.3M | $716.5K | $— | — |
| Q1 null | $62.9M | 33.1% | $5.3M | $716.5K | $— | — |
| Q4 null | $73.5M | 24.7% | $-26.7M | $-33.5M | $— | — |
| FY null | $355.6M | 29.6% | $-41.6M | $-62.0M | $— | — |
| Q3 null | $73.5M | 24.7% | $-26.7M | $-33.5M | $— | — |
| Q2 2023 | $102.4M | 31.9% | $5.8M | $4.9M | $0.11 | — |